Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis

Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis

The reactivation of latent <i>Leishmania</i> infection in chronic diseases and immunocompromised hosts is a broad and heterogeneous field in medicine and infectious diseases. We reported one of the first cases of Visceral Leishmaniasis occurring in a Caucasian middle-aged man living in a...

Full description

Bibliographic Details
Main Authors: Tommaso Lupia, Silvia Corcione, Valentina Fornari, Barbara Rizzello, Roberta Bosio, Maria Teresa Brusa, Francesco Giuseppe De Rosa
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Tropical Medicine and Infectious Disease
Subjects:
<i>Leishmania</i>
psoriasis
arthritis
interleukin-17
secukinumab
Online Access:https://www.mdpi.com/2414-6366/7/10/319

Internet

https://www.mdpi.com/2414-6366/7/10/319

Similar Items